Skip to main content

Advertisement

Log in

Pharmacodynamic analysis of time-variant cellular disposition: reticulocyte disposition changes in phlebotomized sheep

  • Original Article
  • Published:
Journal of Pharmacokinetics and Pharmacodynamics Aims and scope Submit manuscript

Abstract

Most pharmacodynamic (PD) models of cellular response assume a time-invariant (i.e., constant) cellular disposition despite known changes in the disposition with time, such as the reticulocyte residence time in the systemic circulation during stress erythropoiesis. To account for changes in cellular disposition, a comprehensive PD model that involves endogenous erythropoietin (Epo), reticulocytes, and hemoglobin responses was developed in phlebotomized sheep that considers a time-variant reticulocyte residence time and allows for the simultaneous determination of changes in the cellular disposition and cellular production. Five sheep were phlebotomized to hemoglobin concentrations of approximately 4 g/dl. Epo concentrations, reticulocytes, and hemoglobin concentrations were frequently sampled for 5–7 days prior to and 25–30 days following the phlebotomy. Initial steady-state conditions were assumed and the time-variant reticulocyte residence time in the systemic circulation was semiparametrically represented using a constrained spline function. Hemoglobin production was modeled using a Hill function via an effect site compartment. The initial steady state reticulocyte residence time in the systemic circulation was estimated as 0.477 (0.100) (mean (SD)) days, which maximally increased 2.01- to 2.64-fold higher than the initial steady-state residence time 5.95 (0.899) days post-phlebotomy (P < 0.01). On average, the residence time returned to steady-state values 15.4 (2.36) days post-phlebotomy, which was not significantly different from the initial steady-state value (P > 0.05). The baseline hemoglobin production rate was estimated at 0.0929 (0.0472) g/kg/day and the maximum production rate under stress phlebotomy was estimated at 0.504 (0.0422) g/kg/day. These data indicate that endogenously released Epo under acute anemic conditions can increase hemoglobin production approximately 5-fold. The determined increase in reticulocyte residence time produced under stress erythropoiesis is similar to the commonly reported 2- to 3-fold increase observed in human patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • Hoffman R, Benz EJ Jr, Shattil SJ, Furie B, Cohen HJ, Silberstein LE, McGlave P (2005) Hematology: basic principles and applications, 4th edn. Elsevier Inc, USA

    Google Scholar 

  • Brugnara C (1998) Use of reticulocyte cellular indices in the diagnosis and treatment of hematological disorders. Int J Clin Lab Res 28:1–11

    Article  PubMed  CAS  Google Scholar 

  • Brugnara C (2000) Reticulocyte cellular indices: a new approach in the diagnosis of anemias and monitoring of erythropoietic function. Crit Rev Clin Lab Sci 37:93–130

    Article  PubMed  CAS  Google Scholar 

  • Hillman RS, Ault KA, Rinder HM (2005) Hematology in clinical practice, 4th edn. McGraw-Hill Companies, Inc, USA

    Google Scholar 

  • Riley RS, Ben-Ezra JM, Tidwell A, Romagnoli G (2002) Reticulocyte analysis by flow cytometry and other techniques. Hematol Oncol Clin North Am 16:373–420, vii

    Article  PubMed  Google Scholar 

  • Hirose A, Yamane T, Shibata H, Kamitani T, Hino M (2005) Automated analyzer evaluation of reticulocytes in bone marrow and peripheral blood of hematologic disorders. Acta Haematol 114:141–145

    Article  PubMed  Google Scholar 

  • Watanabe K, Kawai Y, Takeuchi K, Shimizu N, Iri H, Ikeda Y, Houwen B (1994) Reticulocyte maturity as an indicator for estimating qualitative abnormality of erythropoiesis. J Clin Pathol 47:736–739

    Article  PubMed  Google Scholar 

  • Pradella M, Cavill I, d’Onofrio G (1996) Assessing erythropoiesis and the effect of erythropoietin therapy in renal disease by reticulocyte counting. Clin Lab Haematol 18:35–37

    PubMed  Google Scholar 

  • Aulesa C, Ortega JJ, Jou JM, Colomer E, Montero J, Olano E, Remacha AF, Martino R, Yoldi F, Escribano I (1994) Flow cytometric reticulocyte quantification in the evaluation of hematologic recovery—Spanish multicentric study-group for hematopoietic recovery. Euro J Haematol 53:293-297

    Google Scholar 

  • Davis BH, Bigelow NC (1989) Flow cytometric reticulocyte quantification using thiazole orange provides clinically useful reticulocyte maturity index. Arch Pathol Lab Med 113:684–689

    PubMed  CAS  Google Scholar 

  • Batjer JD, Riddell K, Fritsma GA (1994) Predicting bone-marrow transplant engraftment by automated flow cytometric reticulocyte analysis. Lab Med 25:22–26

    Google Scholar 

  • Dubner D, Perez MD, Barboza M, Sorrentino M, Robinson A, Gisone P (2002) Prognosis and bone marrow recovery indicators in bone marrow transplantation after total body irradiation. Med Buenos Aires 62:555–561

    Google Scholar 

  • Noronha JFA, De Souza CA, Vigorito AC, Aranha FJP, Zulli R, Miranda ECM, Grotto HZW (2003) Immature reticulocytes as an early predictor of engraftment in autologous and allogeneic bone marrow transplantation. Clin Lab Haematol 25:47–54

    Article  PubMed  CAS  Google Scholar 

  • Houwen B (1992) Reticulocyte maturation. Blood Cells 18:167–186

    PubMed  CAS  Google Scholar 

  • Jandl JH (1996) Blood: textbook of hematology, 2nd edn. Little, Brown and Company, USA

    Google Scholar 

  • Veng-Pedersen P, Chapel, Schmidt RL, Al-Huniti NH, Cook RT, Widness JA (2002) An integrated pharmacodynamic analysis of erythropoietin, reticulocyte, and hemoglobin responses in acute anemia. Pharm Res 19:1630–1635

    Article  PubMed  CAS  Google Scholar 

  • Chapel SH, Veng-Pedersen P, Schmidt RL, Widness JA (2000) A pharmacodynamic analysis of erythropoietin-stimulated reticulocyte response in phlebotomized sheep. J Pharmacol Exp Ther 295:346–351

    PubMed  CAS  Google Scholar 

  • Krzyzanski W, Jusko WJ, Wacholtz MC, Minton N, Cheung WK (2005) Pharmacokinetic and pharmacodynamic modeling of recombinant human erythropoietin after multiple subcutaneous doses in healthy subjects. Eur J Pharm Sci 26:295-306

    Article  PubMed  CAS  Google Scholar 

  • Ramakrishnan R, Cheung WK, Farrell F, Joffee L, Jusko WJ (2003) Pharmacokinetic and pharmacodynamic modeling of recombinant human erythropoietin after intravenous and subcutaneous dose administration in cynomolgus monkeys. J Pharmacol Exp Ther 306:324–331

    Article  PubMed  CAS  Google Scholar 

  • Ramakrishnan R, Cheung WK, Wacholtz MC, Minton N, Jusko WJ (2004) Pharmacokinetic and pharmacodynamic modeling of recombinant human erythropoietin after single and multiple doses in healthy volunteers. J Clin Pharmacol 44:991–1002

    Article  PubMed  CAS  Google Scholar 

  • Krzyzanski W, Ramakrishnan R, Jusko WJ (1999) Basic pharmacodynamic models for agents that alter production of natural cells. J Pharmacokinet Biopharm 27:467–489

    PubMed  CAS  Google Scholar 

  • Krzyzanski W, Woo S, Jusko WJ (2006) Pharmacodynamic models for agents that alter production of natural cells with various distributions of lifespans. J Pharmacokinet Pharmacodyn 33:125–166

    Article  PubMed  CAS  Google Scholar 

  • Al-Huniti NH, Widness JA, Schmidt RL, Veng-Pedersen P (2005) Pharmacodynamic analysis of changes in reticulocyte subtype distribution in phlebotomy-induced stress erythropoiesis. J Pharmacokinet Pharmacodyn 32:359–376

    Article  PubMed  Google Scholar 

  • Widness JA, Veng-Pedersen P, Modi NB, Schmidt RL, Chestnut DH (1992) Developmental differences in erythropoietin pharmacokinetics: Increased clearance and distribution in fetal and neonatal sheep. J Pharmacol Exp Therapeut 261:977–984

    CAS  Google Scholar 

  • Peters C, Georgieff MK, Alarcon PAd, Cook RT, Burmeister LF, Lowe LS, Widness JA (1996) Effect of chronic erythropoietin administration on plasma iron in newborn lambs. Biol Neonate 70:218–228

    PubMed  CAS  Google Scholar 

  • Hutchinson MF, deHoog FR (1985) Smoothing noise data with spline functions. Numer Math 47:99–106

    Article  Google Scholar 

  • Mock DM, Lankford GL, Burmeister LF, Strauss RG (1997) Circulating red cell volume and red cell survival can be accurately determined in sheep using the [14C]cyanate label. Pediatr Res 41:916–921

    Article  PubMed  CAS  Google Scholar 

  • Veng-Pedersen P (1977) Curve fitting and modelling in pharmacokinetics and some practical experiences with NONLIN and a new program FUNFIT. J Pharmacokinet Biopharm 5:513–531

    Article  Google Scholar 

  • Hairer E, Norsett SP, Wanner G (1993) Solving ordinary differential equations I: nonstiff problems, 2nd edn. Springer-Verlag, Berlin

    Google Scholar 

  • Akaike H (1974) Automatic control: a new look at the statistical model identification. IEEE Trans 19:716–723

    Google Scholar 

  • Hillman RS, Finch CA (1967) Erythropoiesis: normal and abnormal. Semin Hematol 4:327–336

    PubMed  CAS  Google Scholar 

  • Hillman RS (1969) Characteristics of marrow production and reticulocyte maturation in normal man in response to anemia. J Clin Invest 48:443–453

    Article  PubMed  CAS  Google Scholar 

  • Shimada A (1975) The maturation of reticulocytes. II. Life-span of red cells originating from stress reticulocytes. Acta Med Okayama 29:283–289

    PubMed  CAS  Google Scholar 

  • Stohlman F Jr (1961) Humoral regulation of erythropoiesis. VII. Shortened survival of erythrocytes produced by erythropoietine or severe anemia. Proc Soc Exp Biol Med 107:884–887

    PubMed  CAS  Google Scholar 

  • Krantz SG, Parks HR (2002) The implicit function theorem: history, theory, and applications. Birkhauser, Boston

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Peter Veng-Pedersen.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Freise, K.J., Widness, J.A., Schmidt, R.L. et al. Pharmacodynamic analysis of time-variant cellular disposition: reticulocyte disposition changes in phlebotomized sheep. J Pharmacokinet Pharmacodyn 34, 519–547 (2007). https://doi.org/10.1007/s10928-007-9056-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10928-007-9056-2

Keywords

Navigation